OSOM Flu SARS-CoV-2 Combo Test Kit - 25 Kits/Box (1080)

MSRP: $269.95
$206.00
(You save $63.95 )
(No reviews yet) Write a Review
SKU:
PST-GEN-1080
  • A rapid, multi-analyte, point-of-care lateral-flow immunoassay it's designed to simultaneously detect and differentiate viral antigens from three major respiratory pathogens using a single patient specimen

Uses

  • Multiplex Respiratory Screening:
    • Simultaneously identifies and differentiates between active infections of Influenza A, Influenza B, and SARS-CoV-2 (COVID-19)
  • Point-of-Care Triage:
    • Deployed in urgent care networks, physician offices, outpatient clinics, and hospitals to manage patients presenting with overlapping viral symptoms
  • Infection Control & Surveillance:
    • Aids clinical teams in quickly isolating contagious patients and tracking community transmission of respiratory seasonal viruses

Features

  • CLIA Waived Status:
    • Certified for decentralized clinical spaces, enabling standard nursing or medical staff to run the assay legally without advanced laboratory equipment
  • Broad Strain Detection:
    • Engineered to identify a wide range of viral variants, including emerging strains such as H5N1 avian bird flu
  • Anterior Nasal Swabbing:
    • Utilizes a minimally invasive, shallow nasal swab to maximize patient physical comfort during collection
  • Commercial 25-Test Layout:
    • Formulated as an all-inclusive box containing 25 visual test devices, pre-filled extraction buffer vials, sterile collection swabs, and a workstation
  • "QC Inside®" Allocation:
    • Ships with 2 extra test sticks strictly designated for external positive and negative quality controls, delivering a total of 27 test sticks per package

Benefits

  • Accelerated Differentiated Results:
    • Delivers clear visual readouts in just 10 minutes from a single swab, enabling fast "test-and-treat" clinical decisions within one brief patient visit
  • Prevents Misdiagnosis:
    • Reduces diagnostic guesswork by isolating exactly which virus is causing upper respiratory distress, shielding patients from ineffective therapies
  • Supports Targeted Antiviral Therapy:
    • Allows physicians to confidently prescribe virus-specific treatments (such as Paxlovid or Tamiflu) or avoid inappropriate antibiotic use
  • Streamlined Clinical Workflows:
    • Requires zero capital equipment, automated readers, or step-by-step fluid formulation because extraction vials come entirely pre-filled